Astellas Pharma Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Japan.
P/E ratio
12.2Investors pay 12.2 for every 1 of Astellas Pharma Inc.'s yearly profit, lower than 72% of Healthcare companies in Japan.
P/B ratio
2.32The share price is 2.32 times Astellas Pharma Inc.'s book value per share, higher than 78% of Healthcare companies in Japan.
Market cap
¥4,509.4 BThe total market value of all of Astellas Pharma Inc.'s shares at today's price (share price × number of shares), larger than 94% of Healthcare companies in Japan. PosiCap size class: Tito Cap.
Return on equity (ROE)
21.3%Astellas Pharma Inc. earned 21.3% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Japan.
Dividend yield
3.18%Astellas Pharma Inc. pays 3.18% of its share price as dividends a year, higher than 64% of dividend-paying Healthcare companies in Japan.
Questions
What is Astellas Pharma Inc.'s P/E ratio?
Investors pay 12.2 for every 1 of Astellas Pharma Inc.'s yearly profit, lower than 72% of Healthcare companies in Japan.
What is Astellas Pharma Inc.'s return on equity?
Astellas Pharma Inc. earned 21.3% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Japan.
Does Astellas Pharma Inc. pay a dividend?
Yes. Astellas Pharma Inc. pays 3.18% of its share price as dividends a year, higher than 64% of dividend-paying Healthcare companies in Japan.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.